NCT02305355View on ClinicalTrials.gov

Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Diabetes Mellitus, Type 2Hypertriglycemia
Interventions
DRUG

Omega-3-acids ethylesters 90 4g

DRUG

Pravastatin, Simvastatin, Atorvastatin, Rosuvastatin

Trial Locations (1)

Unknown

Bucheon St. Mary's Hospital, Bucheon-si

Sponsors
All Listed Sponsors
lead

Kuhnil Pharmaceutical Co., Ltd.

INDUSTRY

NCT02305355 - Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia | Biotech Hunter | Biotech Hunter